Organization
Genentech, South San Francisco, USA
2 abstracts
Abstract
Acute phase reactant levels and prednisone doses at disease flare in patients with giant cell arteritis: prospective data from the giacta trialOrg: Massachusetts Gen Hosp Rheumatol Unit, Harvard Med School, Boston, Genentech, South San Francisco, USA, Roche Products Ltd, Welwyn Garden City, UK, Abteilung für Rheumatologie, Dresden, Germany, University Hospitals Gasthuisberg, Leuven, Belgium,
Abstract
BASELINE DATA ON PATIENTS IN GIACTA (TOCILIZUMAB IN GIANT CELL ARTERITIS) Org: Roche Products Ltd, Welwyn Garden City, United Kingdom, Genentech, South San Francisco, USA, Massachusetts General Hospital, Boston, United States of America,